Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Becker

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
European Heart Journal. Acute Cardiovascular Care|June 25, 2026
Availability of mechanical circulatory support (MCS) and hospital survival in ST-segment elevation myocardial infarction related cardiogenic shock (STEMI-CS)Karl Heinrich Scholz, Florian Weiser, Tim Friede, et al.
Communications Biology|September 17, 2025
Cholinergic network modulation in disinhibited eating behaviorSwen Hesse, Michael Rullmann, Tilman Günnewig, et al.
Brain Sciences|November 11, 2022
Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with ObesityNora-Isabell Griebsch, Johanna Kern, Jonas Hansen, et al.
Neuroimage|June 4, 2015
First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]FlubatineOsama Sabri, Georg-Alexander Becker, Philipp M Meyer, et al.
Brain : a Journal of Neurology|April 20, 2018
Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementiaOsama Sabri, Philipp M Meyer, Susanne Gräf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 16, 2020
(+)-[<sup>18</sup>F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controlsSolveig Tiepolt, Georg-Alexander Becker, Stephan Wilke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2017
Central noradrenaline transporter availability in highly obese, non-depressed individualsSwen Hesse, Georg-Alexander Becker, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography studySwen Hesse, Michael Rullmann, Julia Luthardt, et al.
JAMA Surgery|July 14, 2016
Glasgow Coma Scale Score in Survivors of Explosion With Possible Traumatic Brain Injury in Need of Neurosurgical InterventionItamar Ashkenazi, William P Schecter, Kobi Peleg, et al.
Circulation|August 25, 2010
Differential cardiac remodeling in preload versus afterloadKarl Toischer, Adam G Rokita, Bernhard Unsöld, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
European Heart Journal. Acute Cardiovascular Care|June 25, 2026
Availability of mechanical circulatory support (MCS) and hospital survival in ST-segment elevation myocardial infarction related cardiogenic shock (STEMI-CS)Karl Heinrich Scholz, Florian Weiser, Tim Friede, et al.
Communications Biology|September 17, 2025
Cholinergic network modulation in disinhibited eating behaviorSwen Hesse, Michael Rullmann, Tilman Günnewig, et al.
Brain Sciences|November 11, 2022
Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with ObesityNora-Isabell Griebsch, Johanna Kern, Jonas Hansen, et al.
Neuroimage|June 4, 2015
First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]FlubatineOsama Sabri, Georg-Alexander Becker, Philipp M Meyer, et al.
Brain : a Journal of Neurology|April 20, 2018
Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementiaOsama Sabri, Philipp M Meyer, Susanne Gräf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 16, 2020
(+)-[<sup>18</sup>F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controlsSolveig Tiepolt, Georg-Alexander Becker, Stephan Wilke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2017
Central noradrenaline transporter availability in highly obese, non-depressed individualsSwen Hesse, Georg-Alexander Becker, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography studySwen Hesse, Michael Rullmann, Julia Luthardt, et al.
JAMA Surgery|July 14, 2016
Glasgow Coma Scale Score in Survivors of Explosion With Possible Traumatic Brain Injury in Need of Neurosurgical InterventionItamar Ashkenazi, William P Schecter, Kobi Peleg, et al.
Circulation|August 25, 2010
Differential cardiac remodeling in preload versus afterloadKarl Toischer, Adam G Rokita, Bernhard Unsöld, et al.
Pageof 17